KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CFO Mary Reumuth sold 1,786 shares of KALA BIO stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $6.09, for a total value of $10,876.74. Following the completion of the transaction, the chief financial officer now directly owns 64,350 […]
KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) insider Todd Bazemore sold 2,093 shares of the company’s stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $6.09, for a total transaction of $12,746.37. Following the transaction, the insider now directly owns 87,693 shares of the […]
KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CEO Mark T. Iwicki sold 7,392 shares of the firm’s stock in a transaction dated Friday, May 31st. The stock was sold at an average price of $6.09, for a total transaction of $45,017.28. Following the sale, the chief executive officer now directly owns 278,923 shares in […]
KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CEO Mark T. Iwicki sold 7,392 shares of the business’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $6.09, for a total transaction of $45,017.28. Following the completion of the sale, the chief executive officer now directly owns […]
KALA BIO (NASDAQ:KALA – Free Report) had its price objective reduced by HC Wainwright from $21.00 to $18.00 in a research report sent to investors on Friday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for KALA BIO’s Q1 2025 earnings at ($2.62) EPS, Q2 2025 […]